Verellen D - Search Results

1

Minimum and optimal requirements for a safe clinical implementation of ultra-high dose rate radiotherapy: A focus on patient's safety and radiation protection.

Garibaldi C, Beddar S, Bizzocchi N, Tobias Böhlen T, Iliaskou C, Moeckli R, Psoroulas S, Subiel A, Taylor PA, Van den Heuvel F, Vanreusel V, Verellen D. Garibaldi C, et al. Among authors: verellen d. Radiother Oncol. 2024 Apr 20;196:110291. doi: 10.1016/j.radonc.2024.110291. Online ahead of print. Radiother Oncol. 2024. PMID: 38648991 No abstract available.

2

European Society of Radiotherapy and Oncology (ESTRO) strategy 2024-2026: Growth and diversification in a rapidly changing world.

Kirby AM, Guckenberger M, Slotman BJ, Clark CH, Eriksen JG, van der Heide U, De Ioanna S, Gasparotto C, Cortese AJ; ESTRO Board of Directors. Kirby AM, et al. Radiother Oncol. 2024 Apr 18;196:110283. doi: 10.1016/j.radonc.2024.110283. Online ahead of print. Radiother Oncol. 2024. PMID: 38641262 Free article.

3

Automated determination of the ion-recombination correction factor (k_sat) in ultra-high dose rate electron radiation therapy.

Claessens M, Vanreusel V, Gasparini A, Nascimento LF, Yalvec B, Reniers B, Verellen D. Claessens M, et al. Among authors: verellen d. Med Phys. 2024 Apr 19. doi: 10.1002/mp.17085. Online ahead of print. Med Phys. 2024. PMID: 38639653

4

Multi-institutional generalizability of a plan complexity machine learning model for predicting pre-treatment quality assurance results in radiotherapy.

Claessens M, De Kerf G, Vanreusel V, Mollaert I, Hernandez V, Saez J, Jornet N, Verellen D. Claessens M, et al. Among authors: verellen d. Phys Imaging Radiat Oncol. 2023 Dec 19;29:100525. doi: 10.1016/j.phro.2023.100525. eCollection 2024 Jan. Phys Imaging Radiat Oncol. 2023. PMID: 38204910 Free PMC article.

5

Long-Term Results of a Phase 1 Dose Escalation Trial of Ablative Stereotactic Body Radiation Therapy.

Mercier C, Billiet C, Ost P, Joye I, Meijnders P, Vermeulen P, Dirix L, Verellen D, Dirix P. Mercier C, et al. Among authors: verellen d. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1490-1496. doi: 10.1016/j.ijrobp.2023.12.021. Epub 2023 Dec 25. Int J Radiat Oncol Biol Phys. 2024. PMID: 38151189 Clinical Trial.

6

A geometry and dose-volume based performance monitoring of artificial intelligence models in radiotherapy treatment planning for prostate cancer.

De Kerf G, Claessens M, Raouassi F, Mercier C, Stas D, Ost P, Dirix P, Verellen D. De Kerf G, et al. Among authors: verellen d. Phys Imaging Radiat Oncol. 2023 Sep 23;28:100494. doi: 10.1016/j.phro.2023.100494. eCollection 2023 Oct. Phys Imaging Radiat Oncol. 2023. PMID: 37809056 Free PMC article.

7

Optically stimulated luminescence system as an alternative for radiochromic film for 2D reference dosimetry in UHDR electron beams.

Vanreusel V, Gasparini A, Galante F, Mariani G, Pacitti M, Colijn A, Reniers B, Yalvac B, Vandenbroucke D, Peeters M, Leblans P, Felici G, Verellen D, de Freitas Nascimento L. Vanreusel V, et al. Among authors: verellen d. Phys Med. 2023 Oct;114:103147. doi: 10.1016/j.ejmp.2023.103147. Epub 2023 Oct 5. Phys Med. 2023. PMID: 37804712

8

The use of in-vivo dosimetry to identify head and neck cancer patients needing adaptive radiotherapy.

Fiagan YAC, Bossuyt E, Nevens D, Machiels M, Chiairi I, Joye I, Meijnders P, Gevaert T, Verellen D. Fiagan YAC, et al. Among authors: verellen d. Radiother Oncol. 2023 Jul;184:109676. doi: 10.1016/j.radonc.2023.109676. Epub 2023 Apr 20. Radiother Oncol. 2023. PMID: 37084887 Free article.

9

Assessing the impact of adaptations to the clinical workflow in radiotherapy using transit in vivo dosimetry.

Bossuyt E, Nevens D, Weytjens R, Taieb Mokaddem A, Verellen D. Bossuyt E, et al. Among authors: verellen d. Phys Imaging Radiat Oncol. 2023 Jan 30;25:100420. doi: 10.1016/j.phro.2023.100420. eCollection 2023 Jan. Phys Imaging Radiat Oncol. 2023. PMID: 36820237 Free PMC article.

10

Lung-Heart Outcomes and Mortality through the 2020 COVID-19 Pandemic in a Prospective Cohort of Breast Cancer Radiotherapy Patients.

Vinh-Hung V, Gorobets O, Adriaenssens N, Van Parijs H, Storme G, Verellen D, Nguyen NP, Magne N, De Ridder M. Vinh-Hung V, et al. Among authors: verellen d. Cancers (Basel). 2022 Dec 18;14(24):6241. doi: 10.3390/cancers14246241. Cancers (Basel). 2022. PMID: 36551726 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page